Canada gives full approval to J&J’s single-shot COVID-19 vaccine

Vials labeled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of the Johnson&Johnson logo displayed in this illustration, taken Feb. 9, 2021. REUTERS/Dado Ruvic/Illustration

Nov 24 (Reuters) – Johnson & Johnson (JNJ.N) said on Wednesday that Canada has given full approval to its single-shot COVID-19 vaccine for people aged 18 and older, making it the first full approval for the vaccine worldwide.

The vaccine had previously been approved by the country under an interim order. (https://refini.tv/30Zd5TR)

Canada, which reports an average of 2,563 infections each day and has administered at least 60,101,058 doses of COVID-19 vaccines to date, has given full approval to Moderna Inc. (MRNA.O) and Pfizer Incs (PFE.N) coronavirus vaccines in September.

The country this month approved the use of Pfizer’s COVID-19 vaccine for children ages 5 to 11 and a booster dose for people ages 18 and older. read more

J&J’s coronavirus vaccine is approved for emergency use in many countries, including the United States.

Register now for FREE unlimited access to reuters.com

Reporting by Dania Nadeem in Bengaluru; Editing by Shounak Dasgupta

Our standards: The Thomson Reuters Trust Principles.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *